诉讼事件概述 - 律师事务所Berger Montague于2025年9月11日对LifeMD公司提起集体诉讼 代表2025年5月7日至8月5日期间购入或获得公司股票的投资者 [1] - 诉讼指控公司夸大其竞争地位并发布不切实际的2025年财务指引 [3] - 公司未披露与其RexMD平台相关的客户获取成本上升问题 以及推广肥胖药物Wegovy和Zepbound的相关举措 [3] 公司业务背景 - LifeMD总部位于纽约 主要提供虚拟医疗服务和处方配送服务 [2] - 公司通过RexMD平台开展业务 并涉足肥胖药物推广领域 [3] 诉讼程序信息 - 投资者可在2025年10月27日前申请作为首席原告代表 [2] - 律师事务所Berger Montague成立于1970年 在证券集体诉讼领域具有丰富经验 在费城 明尼阿波利斯等多地设有办公室 [5]

集体诉讼案件 - 诉讼针对LifeMD公司在2025年5月7日至8月5日期间涉嫌证券欺诈行为 寻求为遭受损失的投资者追回损失 [1] - 投资者需在2025年10月25日前申请成为首席原告 但参与赔偿无需承担自付费用或义务 [3] 指控内容 - 公司被指控 materially overstated LifeMD的竞争地位 [2] - 公司在未妥善核算RexMD业务部门客户获取成本上升的情况下 reckless in raising 2025年业绩指引 [2] - 公司未充分披露针对肥胖症治疗药物（包括Wegovy和Zepbound）的客户获取成本 [2] - 公司关于业务运营和前景的陈述被指控存在 materially false and misleading 且缺乏合理依据 [2] 律所背景 - Levi & Korsinsky律所过去20年为受损股东追回数亿美元资金 拥有70多名员工的专业团队 [4] - 该律所连续七年被ISS证券集体诉讼服务评为美国前50大证券诉讼律师事务所之一 [4]

Accessibility StatementSkip Navigation NEW YORK, Sept. 11, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=166350&from= ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/lifemd-inc-loss-submission-form/?id=166130&from=3 CLASS PERIOD: May 7, 2025 to Augus ...

诉讼核心信息 - 律师事务所宣布投资者可就LifeMD公司证券欺诈提起集体诉讼 [1] - 诉讼指控被告在2025年5月7日至2025年8月5日期间未能向投资者披露关键信息 [2] - 指控内容包括公司 materially overstated 其竞争地位以及 recklessly raised 其2025年业绩指引 [2] 具体指控内容 - 被告在提高2025年业绩指引时 recklessly，未恰当核算其RexMD业务部门不断上升的客户获取成本 [2] - 被告亦未恰当核算与销售肥胖治疗药物相关的客户获取成本，包括Wegovy和Zepbound [2] - 因此被告关于公司业务、运营和前景的正面陈述存在 materially misleading 和/或缺乏合理依据 [2] 投资者参与方式 - 有意主导或参与集体诉讼的投资者需在2025年10月27日前采取行动 [2] - 投资者可通过电子邮件、电话或网站联系该律师事务所进行咨询或参与 [3] - 投资者通过电子邮件咨询时需提供邮寄地址、电话号码及所购股数 [4]

SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report. The firm urges investors in LifeMD who suffered significant losses to ...

NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD†or the "Company†) (NASDAQ: LFMD). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. On August 5, 2025, after the market closed, LifeMD reporte ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP is notifying investors about a federal securities class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“LifeMD” or the “Company”). PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION LifeMD, Inc. (NASDAQ: LFMD) Securities Class Action Lawsuit Class Period: May 7, 2025 – August 5, 2025Lead Plaintiff Deadline: October 27, 2025Court: United States District Court for the Eastern District of New York Allega ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in LifeMD, Inc. ("LifeMD, Inc." or the "Company") (NASDAQ: LFMD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeMD, Inc. investors who were adversely affected by alleged securities fraud between May 7, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submis ...

SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired LifeMD, Inc. (NASDAQ: LFMD) securities between May 7, 2025 and August 5, 2025. LifeMD is a leading provider of virtual primary care. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that LifeMD, Inc. (LFMD) Misled In ...